09:50 AM EST - GeneNews Limited : Has applied to the Toronto Stock Exchange for a further extension of the TSX’s Remedial Review Process to allow the Company additional time to demonstrate compliance with the continued listing requirements of the TSX. GeneNews Limited
shares T.GEN are trading unchanged at $0.18.
